Navigation Links
VIA Pharmaceuticals Receives Delisting Notification From NASDAQ
Date:12/29/2009

of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue" or the negative of these terms or other comparable terminology. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond VIA's control and which could materially affect actual results, levels of activity, performance or achievements.

Factors that may cause actual results to differ materially from current expectations include, but are not limited to:

-- our ability to find a market maker to apply and be cleared by the Financial Industry Regulatory Authority to quote our common stock on the OTC Bulletin Board;

-- ability and willingness of active market makers in our common stock to trade our common stock on the Pink Sheets under a "piggyback qualification";

-- our ability to obtain necessary financing in the near term, including amounts necessary to repay the loan from Bay City Capital by the February 28, 2010 maturity date (or earlier if certain repayment acceleration provisions are triggered);

-- our ability to control our operating expenses;

-- our ability to comply with covenants included in the loan from Bay City Capital;

-- our ability to timely recruit and enroll patients in any future clinical trials;

-- our failure to obtain sufficient data from enrolled patients that can be used to evaluate VIA-2291, thereby impairing the validity or statistical significance of our clinical trials;

-- our ability to successfully complete our clinical trials
'/>"/>

SOURCE VIA Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)...  The acceptance of two abstracts on the ... demonstrates continued interest in the Eclipse System, the ... of the abstracts, presented by Catherine Matthews ... Urogynecology and Reconstructive Pelvic Surgery at the University ... Written Abstract on Urogynecology/Pelvic Floor Disorders/Vaginal Surgery. ...
(Date:11/21/2014)... , Nov. 20, 2014 Oxis International, Inc. (OXIS) ... the election of Anthony J. Cataldo as Chief ... Effective November 19, 2014, Ken Eaton resigned ... Board of Directors of Oxis International, Inc. to pursue new ... been named Chief Executive Officer of Oxis International, Inc. Mr. ...
(Date:11/18/2014)... 2014  NxStage ® Medical Inc. (Nasdaq: ... innovative dialysis products , today announced the ... for the in-center, hemodialysis market.  Streamline Express features ... to reduce the amount of labor required for ... touch point contamination sites.  The dialyzer enables achievement ...
Breaking Medicine Technology:LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 2LIFE Study Prominently Featured at Minimally Invasive Gynecology Conference 3OXIS International, Inc. announces Changes in Management Team 2OXIS International, Inc. announces Changes in Management Team 3NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood Tubing Set 2
... VEGAS, Sept. 15 At its regularly scheduled meeting ... American Pacific Corporation (the "Company" or "AMPAC") (Nasdaq: ... Recommended that shareholders at the next Annual ... 80% vote requirement for director election with a simple ...
... Sept. 15 Tunnell Consulting, Inc. announced ... with Campbell Informatics, an integrated services and technology company ... leading life sciences industry consultancy, and Campbell, a provider ... and regulators, is designed to enable both companies to ...
Cached Medicine Technology:American Pacific Adopts Corporate Governance Changes 2Tunnell Consulting Forms Strategic Alliance With Ireland-Based Campbell Informatics 2
(Date:11/22/2014)... November 22, 2014 Domestic farmgate ... slightly in 2009-10, due to a fall in ... industry products amid the global financial crisis. ... strength of Australian dairy manufacturers on the international ... products outweighed supply growth, primarily due to supply ...
(Date:11/22/2014)... Everett, WA (PRWEB) November 22, 2014 The ... beauty and complexity of block retaining walls. The article states ... strength, there are several necessary steps that go into creating ... steps when building a retaining wall is choosing which kind ... desired purpose. , B&D Rockeries says, “The two main ...
(Date:11/22/2014)... has been a historical time for Angeldress.co.uk, an excellent wedding ... some renowned review websites. Recently, the company has added to ... of wonderful sexy wedding dresses to its website. At the ... to an 80% discount on any order over GBP 149. ... dress at Angeldress.co.uk, which has garnered a hard core of ...
(Date:11/22/2014)... 22, 2014 Recently, UWDress.com is gratified ... guest dresses . In addition, the company has also ... , As a leading online supplier of wedding dresses, ... outfits. The unusual best wedding guest gowns are provided ... amazing designs, this new selection is famous for high ...
(Date:11/22/2014)... OR (PRWEB) November 22, 2014 The ... of Roy Baroff to its team of conflict ... mediator, soccer player, coach, and referee. He has over 30 ... Carolina and beyond. , “I'm very excited to connect with ... and sports related interests to a program with a complete ...
Breaking Medicine News(10 mins):Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2Health News:Best Wedding Guest dresses Introduced by UWDress.com 2Health News:SCI Announces New Team Member Roy Baroff 2Health News:SCI Announces New Team Member Roy Baroff 3
... Infectious Diseases (NIAID), part of the National Institutes of Health, ... shut down, and how they can be reactivated. ... that the immune system can use, like the gas pedal ... or to damp down its activity. However, in people with ...
... FRIDAY, June 3 (HealthDay News) -- Poor sleep may be ... research that found that children who bully other kids are ... In the study, researchers from the University of Michigan Medical ... twice as likely to have sleep-disordered breathing problems or ...
... Sexual pleasure among young adults (ages 18-26) is linked to ... by researchers at the Johns Hopkins Bloomberg School of Public ... representative population sample of heterosexuals to find a relationship between ... published in the June 2011 issue of The Journal ...
... tsunami, tornado or flood strike, among the most vulnerable ... Journal of Emergency Management , researchers in New Zealand ... the age-related needs of adults with regards to the ... Tuohy and Christine Stephens of Massey University in Palmerston ...
... early days of the AIDS epidemic, a once-rare form of ... harbinger of HIV. Its stigma was best illustrated by Tom ... cancerous skin lesions from his co-workers in the 1993 movie ... Zhu was a young virologist searching for a postdoctoral position. ...
... Reporter , THURSDAY, June 2 (HealthDay News) -- The emergence ... bacteria in Europe should serve as a red flag for ... and changing. They,re not necessarily becoming more severe, but they ... physician in infectious diseases at North Shore University Hospital in ...
Cached Medicine News:Health News:Kids Who Bully Often Get Poor Sleep 2Health News:Study links empathy, self-esteem, and autonomy with increased sexual enjoyment 2Health News:Helping the aged during natural disasters 2Health News:FSU scientist leads research on AIDS-related cancer 2Health News:FSU scientist leads research on AIDS-related cancer 3Health News:Deadly E. Coli Strain in Europe Should Serve as Warning, Experts Say 2Health News:Deadly E. Coli Strain in Europe Should Serve as Warning, Experts Say 3
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: